Drugs Stories
- The FDA has approved the drug known as remdesivir for the treatment of COVID-19.
- An experimental drug that was recently shown to slow the progression of ALS may have the potential to prolong patient survival.
- The National Institutes of Health announced a new initiative to fight opioid use disorder (OUD).
- The President said he's making arrangements so people in the US can get prescription drugs from Canada. Pharmacists - and the Canadian government - say "not so fast."
- One study says remdesivir helps treat COVID-19, another says it doesn't.
- Neuropathic, nerve, pain is among the hardest pains to treat. A research team looked at four commonly used medications.
- The FDA warns women 20 weeks pregnant or further along should not take NSAIDs as they may cause pregnancy-related complications.
- Despite persistent and ongoing dexamethasone shortages, President Trump received the drug while undergoing treatment for COVID-19. Will you be able to if you need it?
- Eli Lilly has had to halt its government-sponsored phase 3 trial of an antibody treatment for COVID-19.
- Currax Pharmaceuticals LLC received a warning letter from the FDA regarding a misleading ad on Google for Contrave, a weight loss drug.
- More than 50% of older adults hospitalized with heart failure go home with double the number of medications. Polypharmacy can cause adverse interactions.
- Johnson and Johnson is the second pharmaceutical company to have to pause a phase 3 clinical trial for a COVID vaccine.